EUVIMEDEUVIMED entdecken
Open Access

Adrenal rather than central dysfunction limits hypothalamic–pituitary–adrenal axis recovery after chronic glucocorticoid treatment in male mice

Lindsey S Gaston iD, Brenna C Jorgensen, Hannah R Friedman, Marc S Sherman, Joseph A Majzoub iD

Endocrinology · 08.07.2026 · 167 (8)

DOI: 10.1210/endocr/bqag081 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrinology, online erschienen am 17.07.2026. Verfasst von Lindsey S Gaston und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA. Hauptthemen laut MEDLINE: Hypothalamo-Hypophyseal System, Pituitary-Adrenal System, Glucocorticoids, Dexamethasone. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, Pediatric Endocrine Society, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glucocorticoid-induced adrenal insufficiency (GIAI) can persist for months after discontinuation of chronic corticosteroid therapy, placing patients at risk for life-threatening adrenal crises. This prolonged suppression has been attributed primarily to delayed restoration of hypothalamic–pituitary signaling based on indirect measures of central axis activity. To identify the rate-limiting site of hypothalamic–pituitary–adrenal (HPA) axis recovery, we evaluated the timing of functional and histologic recovery at each node of the axis following 8 weeks of dexamethasone (DEX) treatment in adult, male mice. Dexamethasone administration fully suppressed HPA axis activity. Unexpectedly, within 1 week of DEX withdrawal, hypothalamic Crh mRNA and plasma adrenocorticotropic hormone (ACTH) rebounded above control levels, whereas corticosterone (CORT) remained suppressed for an additional 7 weeks. Dexamethasone-treated adrenals were markedly atrophic and contained large clusters of lipid-filled macrophages. Even after adjusting for macrophage content, CORT secretion was disproportionately low relative to the remaining adrenocortical cell mass despite supraphysiologic ACTH stimulation. The adrenal is thus the principal site of postwithdrawal GIAI, involving adrenocortical cell loss and a superimposed defect in steroidogenesis. We next tested whether preserving adrenal trophic signaling during glucocorticoid exposure could prevent GIAI. Adrenal function recovered more slowly in mice treated with DEX and daily cosyntropin (a synthetic ACTH analog) compared to those treated with DEX alone. In contrast, mice with nonsuppressible endogenous ACTH due to targeted hypothalamic deletion of the glucocorticoid receptor maintained normal adrenal architecture and steroidogenic capacity despite prolonged DEX treatment. Pharmacologic treatments that mimic sustained trophic signaling to the adrenal during chronic glucocorticoid treatment may thus prevent GIAI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypothalamo-Hypophyseal SystemPituitary-Adrenal SystemGlucocorticoidsDexamethasoneAdrenal GlandsAdrenal InsufficiencyAnimalsMaleMiceAdrenocorticotropic HormoneCorticosteroneMice, Inbred C57BLCorticotropin-Releasing HormoneReceptors, Glucocorticoid

Stichwörter der Autor:innen

adrenal suppressionglucocorticoidsprevention

Substanzen

GlucocorticoidsDexamethasoneAdrenocorticotropic HormoneCorticosteroneCorticotropin-Releasing HormoneReceptors, Glucocorticoid

Autor:innen und Institutionen

  • Division of Endocrinology, Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.

ORCID-Profile: Lindsey S Gaston, Joseph A Majzoub

Förderung

  • NIDDK NIH HHS
  • Pediatric Endocrine Society
  • NIH HHS
  • Harvard Medical School
  • Boston Children's Hospital
  • NIH
  • Boston Children’s Hospital

Zitieren

APA

Gaston, L. S., Jorgensen, B. C., Friedman, H. R., Sherman, M. S., & Majzoub, J. A. (2026). Adrenal rather than central dysfunction limits hypothalamic–pituitary–adrenal axis recovery after chronic glucocorticoid treatment in male mice. Endocrinology, 167(8). https://doi.org/10.1210/endocr/bqag081

Vancouver

Gaston LS, Jorgensen BC, Friedman HR, Sherman MS, Majzoub JA. Adrenal rather than central dysfunction limits hypothalamic–pituitary–adrenal axis recovery after chronic glucocorticoid treatment in male mice. Endocrinology. 2026;167(8). doi:10.1210/endocr/bqag081

BibTeX
@article{Gaston2026,
  author = {Gaston, Lindsey S and Jorgensen, Brenna C and Friedman, Hannah R and Sherman, Marc S and Majzoub, Joseph A},
  title = {Adrenal rather than central dysfunction limits hypothalamic–pituitary–adrenal axis recovery after chronic glucocorticoid treatment in male mice},
  journal = {Endocrinology},
  year = {2026},
  volume = {167},
  number = {8},
  doi = {10.1210/endocr/bqag081}
}
Kostenlos starten →